Literature DB >> 1110867

Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes.

H Shwachman, E Lebenthal, K T Khaw.   

Abstract

Ten adolescent and young adults with cystic fibrosis (CF) have had well-documented recurrent attacks of acute pancreatitis. The diagnosis of CF in each patient was delayed because they did not have pancreatic insufficiency. The diagnosis of CF was documented by the typical pulmonary involvement and elevated sweat sodium and chloride levels in all cases and a positive family history in six of the ten patients. Two patients were diagnosed as having acute pancreatitis before the diagnosis of CF was made, thus indicating that acute pancreatitis may be the presenting complaint in the young adult with CF. The diagnosis of acute pancreatitis was based on the presence of severe abdominal pain, usually with vomiting, tenderness in the mid-epigastrium, elevated serum and urinary amylase and serum lipase. Attacks were precipitated by fatty meals, alcohol ingestion; postcholecystectomy and tetracycline administration. In some patients no precipitating event could be elicited. Intravenous secretin-pancreozymin stimulation tests revealed a diminished bicarbonate secretion with little effect on the secretion of the zymogen enzymes. A mild attack of pancreatitis occurred after secretin-pancreozymin stimulation. The endocrine pancreatic function tested in four patients was normal as revealed by the glucose tolerance tests and determinations of serum insulin, growth hormone and free fatty acid. Transduodenal pancreatograms were performed in three patients; one showed a normal pancreatic duct, one showed duct obstruction and in the third patient a beady type of narrowing was found. The selenomethionine Se 75 uptake of the pancreas was noted only in the head of the pancreas. This suggests that loss of function occurs initially to a greater extent in the tail and body of the pancreas. Three patients died and showed characteristic lesions of CF.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1110867

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  40 in total

Review 1.  Why should a clinician care about the molecular biology of transport?

Authors:  A J Janecki
Journal:  Curr Gastroenterol Rep       Date:  2000-10

Review 2.  Pathophysiology of the exocrine pancreas in cystic fibrosis.

Authors:  P R Durie; G G Forstner
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

Review 3.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

4.  Isolated lipase and colipase deficiency in two brothers.

Authors:  M Ligumsky; E Granot; D Branski; H Stankiewicz; R Goldstein
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

Review 5.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

Review 6.  Pediatric gastroenterology 1/1/69-12/31/75: a review. Part I. Hollow viscera and the pancreas.

Authors:  M Andorsky; A Finley; M Davidson
Journal:  Am J Dig Dis       Date:  1977-01

Review 7.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Thomas Kelly; James Buxbaum
Journal:  Dig Dis Sci       Date:  2015-02-04       Impact factor: 3.199

8.  Serum or urinary amylase estimations in children with acute abdominal pain.

Authors:  J R Sibert
Journal:  Arch Dis Child       Date:  1977-08       Impact factor: 3.791

9.  Pancreatitis as initial presentation of cystic fibrosis in young adults. A report of two cases.

Authors:  T J Masaryk; E Achkar
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

10.  Longitudinal pancreaticojejunostomy in chronic relapsing pancreatitis with onset in childhood.

Authors:  H W Scott; W W Neblett; J A O'Neill; J L Sawyers; G S Avant; V A Starnes
Journal:  Ann Surg       Date:  1984-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.